Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Analysis of human immunodeficiency virus type 1 drug resistance in children receiving nucleoside analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir (Pediatric AIDS Clinical Trials Group 377).

Eshleman SH, Krogstad P, Jackson JB, Wang YG, Lee S, Wei LJ, Cunningham S, Wantman M, Wiznia A, Johnson G, Nachman S, Palumbo P.

J Infect Dis. 2001 Jun 15;183(12):1732-8. Epub 2001 May 16.

PMID:
11372025
2.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
3.

Stavudine, lamivudine and nevirapine combination therapy for treatment of HIV infection and AIDS in adults.

Siegfried NL, Van Deventer PJ, Mahomed FA, Rutherford GW.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD004535. Review.

PMID:
16625606
4.

HIV-1-resistance-associated mutations after failure of first-line antiretroviral treatment among children in resource-poor regions: a systematic review.

Sigaloff KC, Calis JC, Geelen SP, van Vugt M, de Wit TF.

Lancet Infect Dis. 2011 Oct;11(10):769-79. doi: 10.1016/S1473-3099(11)70141-4. Epub 2011 Aug 25. Review.

PMID:
21872531
5.

Sequencing of antiretroviral therapy in children in low- and middle-income countries.

Sohn AH, Nuttall JJ, Zhang F.

Curr Opin HIV AIDS. 2010 Jan;5(1):54-60. doi: 10.1097/COH.0b013e3283339bd8. Review.

PMID:
20046148
6.
7.

New perspectives for the treatment of HIV infections.

De Clercq E.

Verh K Acad Geneeskd Belg. 1998;60(1):13-41; discussion 41-5. Review.

PMID:
9646721
8.

Antiretroviral therapy: a guide to the most important trials.

Rutschmann O, Hirschel B.

Schweiz Med Wochenschr. 1997 Mar 15;127(11):436-43. Review.

PMID:
9098917
9.

Antiretroviral therapy. Sequencing antiretrovirals.

MacArthur RD.

AIDS Read. 2000 Jun;10(6):359-64. Review.

PMID:
10881367
10.

The role of stavudine in the management of adults with HIV infection.

Moyle GJ, Gazzard BG.

Antivir Ther. 1997 Dec;2(4):207-18. Review.

PMID:
11327440
11.

Prevalence and incidence of resistance to zidovudine and other antiretroviral drugs.

Mayers DL.

Am J Med. 1997 May 19;102(5B):70-5. Review.

PMID:
9845501
12.

Antiretrovirals.

Temesgen Z, Wright AJ.

Mayo Clin Proc. 1999 Dec;74(12):1284-301. Review.

PMID:
10593358
13.

Zidovudine: a review of its use in the management of vertically-acquired pediatric HIV infection.

Bhana N, Ormrod D, Perry CM, Figgitt DP.

Paediatr Drugs. 2002;4(8):515-53. Review.

PMID:
12126455
14.

Antiretroviral chemotherapy.

Saag MS, Schooley RT.

Curr Clin Top Infect Dis. 1998;18:154-79. Review. No abstract available.

PMID:
9779354
16.

Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy.

Humphreys EH, Hernandez LB, Rutherford GW.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD006517. Review. Update in: Cochrane Database Syst Rev. 2010;(6):CD006517.

PMID:
17943914
17.

[Antiretroviral agent nevirapine: its pharmacological action and potential for clinical use].

Takeuchi S, Osugi T.

Nihon Yakurigaku Zasshi. 1999 Oct;114(4):205-11. Review. Japanese.

PMID:
10584233
18.

Nucleoside reverse transcriptase inhibitors and resistance of human immunodeficiency virus type 1.

Johnson VA.

J Infect Dis. 1995 Mar;171 Suppl 2:S140-9. Review.

PMID:
7861019
19.

Choice of antiretroviral drugs for postexposure prophylaxis for children: a systematic review.

Penazzato M, Dominguez K, Cotton M, Barlow-Mosha L, Ford N.

Clin Infect Dis. 2015 Jun 1;60 Suppl 3:S177-81. doi: 10.1093/cid/civ110. Review.

PMID:
25972500
20.

Clinical utility of testing human immunodeficiency virus for drug resistance.

Harrigan PR, Côté HC.

Clin Infect Dis. 2000 Jun;30 Suppl 2:S117-22. Review.

PMID:
10860895

Supplemental Content

Support Center